Cumulative morphine at D3 | ≤ 50 mg (n = 40) | > 50 mg (n = 19) | P |
---|---|---|---|
Age > 40 years old | 11 (28%) | 7 (36.8) | 0.46 |
Gender (male) | 31 (78%) | 13 (68.4) | 0.45 |
ASA class > I | 14 (35%) | 5 (26.3) | 0.50 |
BMI (kg.m−2) | 21 [19–23] | 21 [18–22] | 0.88 |
Preoperative chest tube > 24 h | 26 (65%) | 15 (79%) | 0.27 |
Hypertension | 4 (10%) | 1 (5%) | 0.54 |
Diabetes mellitus | 1 (3%) | 0 (0%) | 0.48 |
Respiratory comorbidity | 0.65 | ||
Asthma | 3 (8%) | 1 (5%) | |
COPD | 3 (8%) | 0 (0%) | |
Interstitial lung disease | 1 (3%) | 0 (0%) | |
Emphysema | 1 (3%) | 1 (5%) | |
Past history of pneumothorax | 11 (28%) | 6 (32%) | 0.74 |
Cannabis chronic use | 12 (30%) | 7 (37%) | 0.59 |
Single-port incision | 38 (95%) | 16 (84%) | 0.16 |
Chemical pleurodesis | 32 (80%) | 14 (74%) | 0.58 |
Pulmonary resection | 23 (58%) | 13 (68%) | 0.42 |
Postoperative chest tube duration > 1 day | 4 (10%) | 1 (5%) | 0.54 |
Duration of surgery > 60 min | 21 (53%) | 13 (68%) | 0.24 |
Anesthetic and analgesic agents | |||
Total dose of sufentanil used (μg/kg) | 0.89 [0.69–1.11] | 0.81 [0.71–1.22] | 0.76 |
Ketamine | 31 (78%) | 15 (79%) | 0.90 |
Intravenous Lidocaine | 26 (65%) | 11 (58%) | 0.59 |
Dexamethasone | 38 (95%) | 17 (90%) | 0.43 |
Acetaminophen | 40 (100%) | 19 (100%) | – |
Nefopam | 39 (98%) | 18 (95%) | 0.58 |
Ketoprofen | 22 (55%) | 11 (58%) | 0.83 |
Tramadol | 39 (98%) | 17 (90%) | 0.19 |
Loco-regional analgesic technique | |||
Systemic analgesia alone | 6 (15%) | 9 (47%) | 0.02 |
Paravertebral catheter | 6 (15%) | 3 (16%) | 0.93 |
Serratus single injection | 12 (30%) | 4 (21%) | 0.47 |
Serratus catheter | 16 (40%) | 3 (16%) | 0.06 |